XML 16 R2.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 287,649 $ 229,902
Marketable securities 415,341 193,436
Total cash, cash equivalents, and marketable securities 702,990 423,338
Accounts receivable, net 173,623 300,173
Unbilled receivables, net 157,281 237,379
Other current assets 85,186 68,137
Total current assets 1,119,080 1,029,027
Long-term unbilled receivables, net 77,576 85,402
Goodwill 81,568 81,611
Other long-term assets 301,008 314,696
Total assets 1,579,232 1,510,736
Current liabilities:    
Accounts payable 20,103 11,290
Accrued expenses 41,236 39,941
Accrued compensation and related expenses 98,033 126,640
Deferred revenue 345,574 377,845
Convertible senior notes, net 501,225 0
Other current liabilities 18,372 21,343
Total current liabilities 1,024,543 577,059
Long-term convertible senior notes, net 0 499,368
Long-term operating lease liabilities 66,750 66,901
Other long-term liabilities 14,916 13,570
Total liabilities 1,106,209 1,156,898
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 200,000 shares authorized; 85,808 and 83,840 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 858 838
Additional paid-in capital 514,173 379,584
(Accumulated deficit) (28,606) (8,705)
Accumulated other comprehensive (loss) (13,402) (17,879)
Total stockholders’ equity 473,023 353,838
Total liabilities and stockholders’ equity $ 1,579,232 $ 1,510,736